Veranstaltungen

Aufzählung

Das Forschungsdesign

Aufzählung

Hintergrundinformationen

Aufzählung

Beteiligte Forschungsinstitute

Aufzählung

Ergebnisse

Aufzählung

Publikationen

Aufzählung

Presse

Aufzählung

Veranstaltungen

Aufzählung

Projekte vor Ort

Aufzählung

Internationale Forschung

Aufzählung

Chronologie

Aufzählung

Häufig gestellte Fragen

Aufzählung

Kontakt

zurück zur Veranstaltungsübersicht

WHO-Workshop: 
Models of Medication supported Treatment for Opioid Addicts

Sportschloss Velen, Germany, 25-27 April 2002

Workshop organized jointly by WHO and Federal Ministry of Health of Germany
Local organizing agency: DLR, Projektträger Gesundheitsforschung, Bonn

Download of the Report "Models of Medication Supported Treatment for Opioid Addicts"

 

Programme

Thursday 25

Opening of the workshop and welcome

K.-T. Schröder, State-Secretary, Federal Ministry of Health of Germany
C. Prüfer-Storcks, State-Secretary, Ministry of Health of North Rhine-Westphalia
H. Nikogosian, Head, Noncommunicable Diseases and Mental Health, WHO

 

Session 1: Heroin-assisted treatment for opioid addicts (Chair: K. Mann, Mannheim, Germany)

J. Rehm (Zurich, Switzerland): Evaluation of the Swiss trial 

W. van den Brink (Amsterdam, The Netherlands): Results of the Dutch trial (see www.ccbh.nl)

M. Krausz (Hamburg, Germany): Concept and status quo of the German trial

M. Casas (Barcelona, Spain): Concept and conditions of the oral heroin trial in Barcelona (Catalunya, Spain)

B. Fischer (Toronto, Canada): Overview on developments in different countries with special emphasis on the North American situation

General discussion

 

Friday 26

Session 2: Developments in medication-assisted withdrawal and pharmacotherapy (Chair: M. Krausz, Hamburg, Germany)

J. Wolfgramm (Tübingen, Germany): Extinction of addiction memory (I)

G. Mundle (Hornberg, Germany): Extinction of addiction memory (II)

R. Spanagel (Mannheim, Germany): New pharmacotherapies

F. Tretter (München, Germany): Withdrawal under anaesthesia

 

Session 3: Differential practice of medication-assisted substitution treatment for opioid addicts (Chair: J. Rehm, Zurich, Switzerland)

E. Buning (Amsterdam, The Netherlands): Activities of the Euronetwork Methadone

G. Fischer (Vienna, Austria): Buprenorphine and slow-release morphine in the treatment of opioid dependence

U. Verthein (Hamburg, Germany): German experience with medication-assisted substitution treatment

G. Woody (Philadelphia, USA): Methadone treatment in the USA

L. Sakoman (Zagreb, Croatia): The experience with methadone maintance programmes in Croatia

J. Strang (London, UK): Injectable methadone prescribing in the UK: rationale, extent of the practice, and the lack of scientific study

M. Auriacombe (Bordeaux, France): Buprenorphine based treatment

A. Elkashef (NIDA, USA): The development of buprenorphine for the treatment of opiate addiction in the USA

 

Saturday 27

Session 4: Psychosocial interventions and their significance for treatment (Chair: C. Zenker, Münster, Germany)

R. Basdekis-Josza (Hamburg, Germany): Psychoeducation in the German heroin trial

I. Vogt (Frankfurt, Germany): Case-Management / Motivational Interviewing in the German heroin trial

G. Bühringer (München, Germany); Impact of payments on patient compliance

G. Woody (Philadelphia, USA): Psychosocial treatments for cocaine dependents

 

Concluding remarks and farewell

J. Rehm, Zurich, Switzerland
M. Köhler, German Ministry of Health, Bonn
P. Lazarov, WHO Regional Office Europe, Kopenhagen

zurück zur Veranstaltungsübersicht

    Updated: 21.04.06